Overall, AML is characterized by the presence of gene mutations encoding gene expression regulators, like MLL-AF9 fusion gene that disrupts expression of the genes regulating hematopoietic stem cells self-renewal, differentiation and survival [18]. The gene discussed is MLLT3; the disease is acute myeloid leukemia.